Wolverine Trading, LLC Chemo Centryx, Inc. Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$15.36 - $27.51 $162,017 - $290,175
10,548 New
10,548 $269,000
Q4 2021

Feb 14, 2022
SELL
$18.38 - $40.5 $352,326 - $776,344
-19,169 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$13.18 - $19.83 $586,430 - $882,316
-44,494 Reduced 69.89%
19,169 $375,000
Q2 2021

Aug 06, 2021
BUY
$9.59 - $50.88 $610,528 - $3.24 Million
63,663 New
63,663 $897,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email